Carrellizumab + Capecitabine
SYSKY-2023-1282-02
Phase 3 small_molecule active
Quick answer
Carrellizumab + Capecitabine for Breast Neoplasms is a Phase 3 program (small_molecule) at Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Indication
- Breast Neoplasms
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active